Revance Therapeutics Inc - RVNC Sales Growth YoY (Last Twelve Months)

Brandmark of Revance Therapeutics Inc (RVNC)

The investment potential of Revance Therapeutics (RVNC) is based on outsourcing production and logistics to external partners. Year-over-year revenue dynamics over the last 12 months confirm this trend, with the indicator value standing at 97.00. Growth is driven by physician loyalty to the long-acting Daxxify and the implementation of robotic filling lines with AI-driven purity control, ensuring high product quality.

RVNC Revance Therapeutics Inc: Sales Growth YoY (Last Twelve Months) in the range 02/11/2024 - 02/20/2024

Revance Therapeutics Inc (RVNC) - metric breakdowns and financial figures

- market value and analyst target forecast:
Fundamental company valuation:Revance Therapeutics
Mass-produced product of Revance Therapeutics, Inc

This indicator measures the percentage change in revenue over the last 12 months relative to the same period last year, allowing investors to filter out short-term noise and assess the true pace of business expansion. By analyzing the rolling 12-month sales growth rate year-over-year, one can track the impact of Daxxify filling line robotization and the implementation of AI control on the real scalability of operating revenues at Revance Therapeutics (RVNC).